JAMA · 1969 · 44 citations · 13 references
MedicineInternal MedicineClinical EpidemiologyGastroenterologyPatient SafetyAcute Gastrointestinal HemorrhageGastrointestinal BleedingSpontaneous Reporting SystemsClinical MonitoringGastrointestinal Bleeding AssessmentGastrointestinal Bleeding MonitoringGastrointestinal Illness SurveillanceRoutine Health MonitoringSurveillance System Design
An association (<i>P</i>< 0.0001) between the administration of ethacrynic acid and the occurrence of gastrointestinal bleeding was observed during routine computer monitoring of data obtained in a drug-surveillance program. This prompted a detailed analysis wherein diagnosis, age, sex, blood urea nitrogen levels, the presence or absence of heparin sodium therapy, and the severity of illness were controlled. Even after these adjustments, the frequency of gastrointestinal bleeding among patients receiving ethacrynic acid was higher than in those patients who received furosemide, meralluride sodium and/or hydrochlorothiazide and/or chlorothiazide orally, or in those who received none of these diuretics (<i>P</i>< 0.02). The difference noted with ethacrynic acid was confined to the subgroup of patients who received the drug intravenously.
13
Studies on Ethacrynic Acid in Patients with Refractory Edema
John Maher · Annals of Internal Medicine · 1965 · 152 citations
Assessment of Adverse Reactions Within a Drug Surveillance Program
Ivan T. Borda · JAMA · 1968 · 139 citations
The design and logic of a monitor of drug use
D. J. Finney · Journal of Chronic Diseases · 1965 · 126 citations